
Opinion|Videos|October 10, 2017
Choosing Second-Line Therapy for Patients With Urothelial Carcinoma
Author(s)Sumanta Kumar Pal, MD
Sumanta K. Pal, MD, medical oncologist, assistant clinical professor, Department of Medical Oncology and Therapeutics Research, City of Hope, discusses choosing second-line therapy for patients with urothelial carcinoma.





































